Self-Administered Acupressure for Chronic Back Pain
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine if self-administered acupressure can help Veterans relieve chronic low back pain. Acupressure, a technique from Traditional Chinese Medicine, involves applying pressure to specific points on the body. Participants will be divided into two groups: one will start using an acupressure app immediately, while the other will wait 10 weeks to begin. Veterans who have experienced low back pain for at least three months and on most days may be suitable for this study. As an unphased trial, this study offers Veterans the opportunity to explore a non-invasive treatment option for managing chronic pain.
Do I have to stop taking my current medications for the trial?
The trial protocol does not specify if you need to stop taking your current medications. However, you must not have changed your pain medication regimen in the past 4 weeks to be eligible.
What prior data suggests that self-administered acupressure is safe for treating chronic back pain?
Research shows that self-administered acupressure is very safe to try. Studies have found it has little to no side effects, allowing use without healthcare provider supervision. Participants in these studies reported feeling less pain and fatigue without major issues. This makes self-administered acupressure a promising option for safely managing chronic low back pain.12345
Why are researchers excited about this trial?
Researchers are excited about self-administered acupressure for chronic back pain because it offers a non-invasive, drug-free alternative to standard treatments like painkillers and physical therapy. Unlike medications that may have side effects or require prescriptions, acupressure is a self-care technique that involves applying pressure to specific points on the body to relieve pain. This method empowers individuals to manage their pain independently, potentially reducing dependency on medications and frequent doctor visits. Additionally, acupressure can be practiced anywhere, making it a convenient option for those seeking more control over their pain management.
What evidence suggests that self-administered acupressure is effective for chronic back pain?
Research has shown that self-administered acupressure can greatly reduce long-lasting low back pain. One study found that participants who practiced acupressure experienced 35-36% less pain and felt 26% less tired, indicating increased energy. This trial will compare participants who receive access to the acupressure intervention with those in a waitlist control group. Although more research is needed, these early findings suggest that acupressure could be a helpful way to manage chronic back pain.12367
Who Is on the Research Team?
Sarah L. Krein, PhD RN
Principal Investigator
VA Ann Arbor Healthcare System, Ann Arbor, MI
Are You a Good Fit for This Trial?
This trial is for Veterans with chronic low back pain who are enrolled at VA Ann Arbor Healthcare System. They must have had a pain severity of at least 4/10 for over three months and be medically stable, without hospital stays or changes in pain meds recently. Pregnant individuals, those with recent back surgery or acupressure treatments, or cognitive impairments that affect consent ability cannot participate.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Introduction
Participants attend an introductory acupressure class and complete a baseline survey
Treatment
Participants in the intervention group perform self-administered acupressure daily for 6 weeks
Follow-up
Participants are monitored for persisting effects of acupressure after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Self-Administered Acupressure
Self-Administered Acupressure is already approved in United States, European Union for the following indications:
Find a Clinic Near You
Who Is Running the Clinical Trial?
VA Office of Research and Development
Lead Sponsor